ICD-10-CM Billable Code

E88.41

MELAS syndrome

Clinical Classification Guidelines

Inclusion Terms

  • Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes

Medical Intelligence & Overview

MELAS syndrome is a rare, genetic disorder that affects many parts of the body, particularly the brain and muscles. The term MELAS is an acronym that stands for Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes. It is caused by mutations in mitochondrial DNA, leading to problems with energy production within cells. Symptoms can vary widely among individuals, and the condition often begins in childhood or early adulthood. Due to its complex nature, understanding MELAS syndrome requires insight into how mitochondria work and what happens when they malfunction.

Causes & Symptoms

Clinical Causes: Genetic mutations in mitochondrial DNA Inherited from mother, as mitochondria are passed down maternally Potential spontaneous mutations that occur without family history

Key Symptoms: Muscle weakness and exercise intolerance Seizures Stroke-like episodes that may cause temporary neurological deficits Developmental delays in children Hearing loss Drooping eyelids (ptosis) Gastrointestinal issues such as nausea or vomiting Lactic acidosis resulting in fatigue and rapid breathing Cognitive impairments and behavioral changes Fatigue and muscle pain

Diagnostic & Treatment

Diagnosis Path: Diagnosing MELAS syndrome involves a combination of medical history review, neurological examinations, and specific tests. Key diagnostic approaches include: - Blood tests to measure lactate and pyruvate levels, which are often elevated - Brain imaging, such as MRI, to identify stroke-like lesions - Muscle biopsies to observe mitochondrial abnormalities - Genetic testing to identify mutations in mitochondrial DNA - Electromyography (EMG) to assess muscle function Since symptoms can be varied, a multidisciplinary approach is often necessary to confirm the diagnosis.

Treatment Protocols: While there is currently no cure for MELAS syndrome, treatment aims to manage symptoms and improve quality of life. Common strategies include: - Use of supplements like Coenzyme Q10, L-arginine, and antioxidants to support mitochondrial function - Seizure management with anticonvulsant medications - Physical therapy to maintain muscle strength and mobility - Speech and occupational therapy to assist with cognitive and motor challenges - Regular monitoring for stroke-like episodes to provide prompt intervention - Addressing lactic acidosis through dietary modifications or medications as needed Since MELAS is a complex disorder, treatment plans are personalized, and patients often require care from a team of specialists, including neurologists, genetic counselors, and physical therapists.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E88.41 a billable ICD-10 code?
Yes, E88.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E88.41?
Clinical documentation must specify the nature of MELAS syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference